William Shepard, a director at CME Group (CME), recently bought 292 shares. The buy increased his position by less than 1 percent, and came to a total price of $58,326.
The director has made two other buys earlier this year, one for 322 shares, and one for 506 shares. In total, he’s bought over $200,000 in shares this year. A few company executives and directors were sellers of shares over the summer.
Overall, company insiders own 0.5 percent of the company.
The stock exchange owner is up 25 percent over the past year, slightly beating out the S&P 500. Trading volumes are still under the 2020/2021 era high, but are coming back strongly.
CME Group has grown revenues by 10 percent and earnings by nearly 17 percent in the past year. Best of all for shareholders, the company has a massive 57 percent profit margin.
Action to take: Shares are at an average valuation for the company of about 20 times earnings, so investors may want to buy a position now and use any drop lower to add to that stake.
At present, shares yield about 2.2 percent, and CME Group has a history of growing its dividend payout.
For traders, the January 2024 $230 calls, last going for about $2.70, could see mid-to-high double-digit growth on a year-end market rally.
Disclosure: The author of this article has no position in the company mentioned here, but may trade after the next 72 hours. The author receives no compensation from any of the companies mentioned in this article.